NewLimit
NewLimit is a biotechnology company focusing on developing epigenetic reprogramming therapies that aid with illnesses that are normally associated with aging.
2
Funding Rounds
$170.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Bl*** By*** |
|
- | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company NewLimit has raised a total of $170m in funding over 2 rounds.
Key Insights:
- NewLimit May 2025 Series B Funding Round: $130m
- NewLimit Series A round, May 16, 2013: $40m
NewLimit May 2025 Series B Funding Round
$130m
NewLimit Series A round, May 16, 2013
$40m
Industries
NewLimit is active in the following industries: